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Abstract 
 Autism spectrum disorder (ASD) is a condition that consists of deficits in social 
communication as well as restricted, repetitive interests or behaviors.  Individuals with 
ASD also often have comorbid psychiatric and medical disorders.  One such concern is 
high rates of seizures and epilepsy.  Researchers have found that rates of seizures tend to 
be higher in individuals with ASD who also have more impaired functioning. However, 
few studies have examined how the presence of seizures is related to symptoms of ASD.  
The current study aimed to expand the extant literature by investigating whether a history 
of seizures is associated with ASD symptomology across different domains (i.e., 
Socialization/Nonverbal Communication, Restricted Interests/Repetitive Behaviors, 
Communication), as measured by the BISCUIT-Part 1.  Young children with atypical 
development without a diagnosis of ASD or a history of seizures were found to have the 
lowest endorsement of overall ASD symptomology as well as across subscales.  
Individuals with seizures but without an ASD diagnosis had the second lowest scores, 
followed by individuals with both ASD and seizures.  The ASD without a history of 
seizures group had the highest ASD symptomology scores.  These results indicate that, 
for atypically developing individuals without ASD, a history of seizures was related to 
higher levels of autism symptomology.  Conversely, for young children with ASD, a 
history of seizures was related to lower endorsement of autism symptoms than those 
without a history of seizures.  These findings support the need for early identification of 
both ASD and seizure disorders, as both diagnoses have significant implications for 
treatment.  Future directions for research are discussed. 
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Introduction 
 Autism spectrum disorder (ASD) is a neurodevelopmental disorder that involves 
impairments in social communication as well as restricted, repetitive behaviors, interests, 
and activities (American Psychiatric Association, 2013; Tidmarsh & Volkmar, 2003).  
Although prevalence rates of ASD have increased in recent years (Baio, 2014), little is 
known regarding the etiology or underlying mechanisms of the disorder.  Research on 
neurological or physiological abnormalities related to ASD have been largely 
inconclusive.  Although the potential biological underpinnings are still under 
investigation, researchers have suggested that the high prevalence of seizures and 
epilepsy within the disorder may indicate neurological differences in individuals with 
ASD (Bolton et al., 2011; Danielsson, Gillberg, Billstedt, Gillberg, & Olsson, 2005; Frye, 
2016; Levisohn, 2007; Tuchman & Rapin, 2002).  
 Several factors have been found to be related to risk of seizures in ASD, including 
intellectual functioning, gender (Amiet et al., 2008; Bolton et al., 2011), and autism 
severity (Gabis, Pomeroy, & Andriola, 2005).  However, some researchers have 
suggested that cognitive functioning underlies all of these associations, as lower 
intellectual functioning in ASD is often related to female gender (Danielsson et al., 
2005).  As the mechanism behind the relationship between ASD and seizures is 
unknown, further investigation of factors associated with the presence of seizures in ASD 
may help researchers and clinicians to better understand their co-occurrence.  
 The aim of the present study is to further investigate differences in ASD symptom 
severity in individuals with comorbid ASD and seizures.  Groups based on ASD 
diagnosis and a history of seizures were compared to further elucidate whether seizures 
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and seizure disorders are associated with overall ASD symptom severity and/or specific 
symptoms (i.e., communication, socialization/nonverbal communication, repetitive 
behavior/restricted interests).  Further, the current study aims to expand the extant 
literature, which has focused primarily on children, adolescents, and adults, by 
investigating these differences in a sample of infants and toddlers.  This will serve to 
further elucidate whether differences in symptomology are evident at a young age.   
Autism Spectrum Disorder  
 History of ASD 
 The first reports of conditions comparable to ASD were described by Leo Kanner 
in 1943.  Kanner (1943) described the heterogeneity of symptom presentation in 11 
children, and drew parallels across the following symptoms: failure to relate to others; 
marked “autistic aloneness”; failure to change body posture in anticipation of being held; 
differences in verbal abilities; superior memory; delayed echolalia; replication of 
personal pronouns in speech without altering them to be grammatically correct; 
hypersensitivity to loud noises and sudden movements; repetitive repetition of 
verbalizations; need for maintenance of sameness; limited variety of spontaneous 
activity; and ability to maintain interest in objects.  Kanner further noted that the parents 
of all of these children were intelligent and very few were “warmhearted”, and therefore 
suggested that the desire for “aloneness” may be associated with parental characteristics.  
He also highlighted the fact that these children seemed to have adequate or high cognitive 
abilities.  Finally, Kanner attributed the characteristic failure to relate to others to an 
innate, biological deficit, describing them as “inborn autistic disturbances of affective 
contact (Kanner, 1943).   
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 In a follow-up study published nearly 30 years later, Kanner revisited these 11 
individuals and reported on their current status (Kanner, 1971). In childhood, the 
participants were described as having relatively good overall health.  Although large head 
circumference and gross motor difficulties were noted in some, fine motor skills were not 
found to be impaired. Two of the children developed epileptic seizures, one in childhood 
and one in adulthood.  In contrast to his original finding that the intellectual functioning 
of these children seemed to be close to average, in adulthood four were found to have 
extremely low IQ.  In both the original and follow up study, Kanner sought to 
differentiate autism from childhood schizophrenia.  He stated that while there were some 
similarities, symptoms across the two disorders differed in many ways (Kanner, 1971).  
Kanner further cited the fact that schizophrenia usually emerges as a change in behavior, 
while the symptoms reported in children with autism seem to have been present from 
birth (Kanner, 1943).   
 This view was supported by Kanner’s contemporary, Michael Rutter, who 
outlined additional differences between schizophrenia and autism.  These distinctions 
included sex ratio (i.e., schizophrenia has roughly equal prevalence rates in males and 
females, while autism is much more common in males) as well as family socioeconomic 
status (i.e., parents of children with autism tend to have higher intelligence and 
socioeconomic status [SES] than the general population, while parents of individuals with 
schizophrenia typically have average intelligence and SES).  Additionally, a family 
history of schizophrenia is considered a risk factor for developing schizophrenia, while 
individuals with infantile autism rarely have a relative with schizophrenia.  Rutter also 
found that individuals with autism tend to have lower than normal IQ with discrepancies 
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between domains, as visuo-spatial abilities tend to be high while verbal abilities are often 
low.  Hallucinations and delusions, which are characteristic of schizophrenia, are not 
common in autism.  Finally, Rutter maintained Kanner’s assertion that autism symptoms 
are stable over the lifespan, while the severity of symptoms of schizophrenia may change 
over time (Rutter, 1968).  The distinction between autism and schizophrenia was central 
in paving the way for autism to be recognized as a separate disorder. 
 While researchers consistently found support for discrepancies between autism 
and schizophrenia, Rutter’s findings did differ from Kanner’s assertions in that he found 
that children with autism had lower intellectual functioning than the general population 
(Rutter & Schopler, 1987), which is consistent with current estimates of intellectual 
disability in 70% of individuals with ASD (Mannion, Leader, & Healy, 2013; Matson & 
Nebel-Schwalm, 2007; Newschaffer et al., 2007).  However, children with autism 
differed from individuals with intellectual disability in several ways.  First, though both 
groups share an increased prevalence rate of seizures, seizures tend to begin later 
(typically in adolescence) for individuals with ASD.  There are also differences regarding 
co-occurring genetic disorders, as well as the previously mentioned sex difference, which 
is not observed in individuals with intellectual disability (Rutter & Schopler, 1987).  
Early research on autism therefore supported its distinction as a separate, unique disorder.  
 Diagnostic Criteria 
 Diagnostic criteria for ASD have changed significantly in recent years.  ASD was 
first recognized as a disorder in the American Psychiatric Association’s (APA) 
Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III; 
American Psychiatric Association, 1980), which included infantile autism, childhood-
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onset pervasive developmental disorder (PDD), and atypical PDD.  One of the primary 
differentiations between these diagnoses was that infantile autism must have onset before 
30 months of age, while childhood PDD may emerge between 30 months and 12 years.  
Atypical PDD included those individuals who did not meet criteria for either of the other 
two types, but had atypical developmental in several domains.  
 In the Diagnostic and Statistical Manual of Mental Disorders, Third Edition- 
Revised (DSM-III-R; American Psychiatric Association, 1987), these subtypes were re-
classified as Autistic Disorder and Pervasive Developmental Disorder- Not Otherwise 
Specified (PDD-NOS).  Although Autistic Disorder included a specifier if age at onset 
was after 36 months, the general requirement was emergence during infancy or 
childhood.  The three general criteria for Autistic Disorder were impairments in social 
interaction, impairment in verbal and nonverbal communication, and the presence of 
restricted activities and interests.  The criteria for PDD-NOS were similar to that for PDD 
in DSM-III: impairment in development, but the individual did not meet full criteria for 
Autistic Disorder.  
 The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV; American Psychiatric Association, 2000) represented a shift toward 
classification based on severity.  The categories of PDD in DSM-IV included Autistic 
Disorder, Asperger’s disorder, Rett’s Disorder, Childhood Disintegrative Disorder, and 
PDD-NOS.  The criteria for Autistic Disorder and PDD-NOS were relatively similar to 
the previous DSM version; however, the inclusion of Asperger’s disorder represented a 
classification for individuals who had deficits in social interaction and exhibited 
restricted, repetitive, and stereotyped behavior and/or interests, but without deficits in 
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communication or language.  Rett’s disorder and Childhood Disintegrative Disorder both 
involved the loss of previously acquired skills, though the criteria for Rett’s included 
more emphasis on psychomotor development and earlier regression (i.e., 5-48 months), 
while Childhood Disintegrative Disorder involved typical development for at least the 
first two years of life, followed by regression of expressive or receptive language, social 
skills, adaptive behavior, bowel or bladder control, play skills, or motor skills. Childhood 
Disintegrative Disorder also required impairments in at least two of the three areas of 
impairment necessary for an autistic disorder diagnosis.  
 The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-
5; (American Psychiatric Association, 2013) marked an important shift in both the 
diagnostic criteria as well as the categories for autism.  A key change was that the 
separate disorders were combined into a singular disorder with different levels of 
symptom severity.  Autistic Disorder, Asperger’s Disorder, and PDD-NOS were merged 
into one diagnostic category: autism spectrum disorder.  Additionally, the social and 
communication categories were combined into one domain of social communication and 
social interaction.  Childhood disintegrative disorder is no longer classified as separate 
developmental disorder, and Rett disorder is now considered a neurologic disorder with a 
known genetic cause; therefore, both are not included in the most recent version of the 
DSM (Volkmar & Reichow, 2013).  
The current criteria for a diagnosis of ASD include persistent impairments in 
social communication/interactions across settings and restricted, repetitive patterns of 
behavior, interests or activities.  The diagnostic criteria also require that symptoms be 
present early in childhood and that they impair or limit functioning.  For the social 
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communication and interaction category, impairments must be present in: 1) social-
emotional reciprocity (e.g., impairments in initiation of social interaction, sharing of 
interests or emotions; social imitation); 2) nonverbal communication that is relevant to 
socialization (e.g., impairments in eye contact, understanding and using body language, 
speech intonation/volume/rhythm; affect); 3) developing and sustaining relationships 
(beyond those with caregivers; e.g., impairments in theory of mind, adjusting behavior 
based on social context, imaginative play, interest in others).  In regard to the restricted, 
repetitive patterns of behavior, interests, or activities, at least two of the following four 
criteria must be met: 1) stereotyped or repetitive speech, motor movements, or object use 
(e.g., pedantic or formal language, echolalia, pronoun reversal, perseverative language, 
stereotyped or repetitive movements or use of objects); 2) excessively sticking to 
routines, patterns of behavior, or resistance to change (e.g., adherence to routine, 
ritualized patterns of verbal and nonverbal behavior, resistance to change, rigid thinking); 
3) exceedingly limited, fixated interests that are unusual in intensity or focus (e.g., 
narrow range of interests, attachment to unusual inanimate objects; preoccupations or 
obsessions); 4)  over-reactivity or under-reactivity to sensory stimuli or unusual sensory 
interests (e.g., high tolerance to pain, interest or fascination with watching movement of 
objects, such as spinning wheels or fans, licking or smelling objects; APA, 2013).   
Although ASD is considered one singular disorder, it includes three levels of 
symptom severity.  ASD Level 1 specifies that the functional impairments related to the 
disorder require support; Level 2 indicates that the deficits require substantial supports; 
and Level 3 reflects that the impairments require very substantial support.  Several 
specifiers have also been included to denote comorbidities. These include: with or 
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without accompanying intellectual impairment; with or without accompanying language 
impairment; associated with a known medical or genetic condition or environmental 
factor; associated with other neurodevelopmental, mental, or behavioral disorders; and 
with catatonia (APA, 2013).   
Many of the diagnostic items in the DSM-IV-TR communication category now 
fall under social communication or restricted, repetitive behavior, interests, and activities.  
Impairments in social communication and interaction must also be present in multiple 
settings.  Furthermore, while restricted, repetitive behaviors and interests (RRBIs) were 
not a requirement for a diagnosis under DSM-IV, these behaviors are now a mandatory 
criterion for ASD.  Individuals who present with deficits in social communication but do 
not have RRBIs instead typically qualify for Social (Pragmatic) Communication 
Disorder.  Additional changes include: abnormal sensory responses are now included; 
symptoms do not have to manifest prior to age 3; dual diagnosis of comorbid conditions 
(e.g., ADHD) are now permitted; and historical report of behavioral symptoms can be 
included in the diagnostic process (APA, 2013).  
 Prevalence of ASD 
 Although autism was once considered to be a relatively uncommon disorder, 
occurring in as few as 3 or 5 children out of 10,000, prevalence rates have risen in recent 
years (Howlin, 2006).  The most current estimated prevalence is approximately 1 in 68 
children (Baio, 2014). Additionally, there is a well-established sex difference, as males 
are four to five times more likely to have ASD than females (Baio, 2014; Howlin, 2006).  
Some considerations that may account for recent increases in prevalence rates include an 
increase in awareness, changes in diagnostic criteria, improved methodology of research 
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studies, cultural influences, and improvements in assessment and diagnostic practice 
(Fombonne, 2009; Matson & Kozlowski, 2011; Volkmar, Lord, Bailey, Schultz, & Klin, 
2004).  ASD can potentially be diagnosed as young as 18 months of age (Chawarska et 
al., 2014); however, many children do not receive a diagnosis until later in childhood 
(Shattuck et al., 2009).   
Comorbid Conditions 
 Psychiatric comorbidities are common in individuals with ASD.  Simonoff and 
colleagues (2008) found that 70% of children with ASD had at least one comorbid 
condition and 41% had two or more.  Common comorbidities include anxiety disorder, 
attention-deficit hyperactivity (ADHD) disorder, oppositional defiant disorder, and mood 
disorders (Leyfer et al., 2006; Simonoff et al., 2008).  Individuals with ASD also have 
high rates of medical conditions, including gastrointestinal issues, sleep concerns 
(Mannion et al., 2013; Mazurek et al., 2012; Mazurek & Petroski, 2015) and genetic 
conditions such as tuberous sclerosis, Fragile X syndrome, and Angelman syndrome 
(Moss & Howlin, 2009).  Additionally, seizure disorders are a medical comorbidity that 
have been widely studied within this population (Danielsson et al., 2005; Frye, 2016; 
Jokiranta et al., 2014; Mannion et al., 2013; Saemundsen, Ludvigsson, Hilmarsdottir, & 
Rafnsson, 2007).  The identification and treatment of comorbid disorders in individuals 
with ASD is crucial, as these conditions can often exacerbate impairments in functioning 
(Mazurek, 2016).  
Seizures 
 A seizure is a “transient occurrence of signs and/or symptoms due to abnormal 
excessive or synchronous neuronal activity in the brain” (Fisher et al., 2005).  Epilepsy is 
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a disorder that involves a predisposition to epileptic seizures, and typically is defined as 
recurrent seizures (Reilly & Gillberg, 2016).  Epilepsy is a common neurological disorder 
(Reilly & Gillberg, 2016) and Hesdorffer and colleague (2011) estimated that the lifetime 
prevalence of epilepsy is 1 in 26 people.  The results of several studies indicate that the 
risk of developing epilepsy may be greater at a younger ages and decreases during 
puberty and into adulthood (Camfield, Camfield, Gordon, Wirrell, & Dooley, 1996; 
Danielsson et al., 2005).  
Types of Seizures 
 There are several different types of seizures, all of which fall into two categories: 
generalized or partial/focal (Reilly & Gillberg, 2016).  Generalized seizures originate 
within bilateral networks and the location and lateralization are not the same for all 
seizures.  This class of seizures includes tonic-clonic, absence, myoclonic, clonic, tonic, 
and atonic seizures (Berg et al., 2010).  Tonic-clonic seizures, also known as grand mal 
seizures, affect the entire body and are characterized by convulsions that cause muscle 
rigidity and contractions.  Absence seizures often present as blank facial affect and 
unresponsiveness, and are classified as either typical or atypical. Typical absence seizures 
often have a short duration and include impaired consciousness.  Atypical absence 
seizures have a longer duration and often include tonic, clonic, or automatic movements 
(Holmes, 1997).  Tonic seizures are usually brief and involve increased muscle tone in 
extensor muscles as the muscles contract and stiffen.  Consciousness is also often 
impaired.  Clonic seizures cause muscles to spasm, which results in jerking muscle 
motions, while myoclonic seizures are short jerks of a muscle or groups of muscles, 
similar to the characteristic physical response to shock.  Lastly, atonic seizures usually 
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involve loss of muscle tone, which can result in the person falling or in the dropping of 
the head or slumping of the body (McCandless, 2012).  Consciousness is sometimes also 
impaired, and myocolonic jerks often occur after the atonic episodes.  This type of 
seizure occurs most often in children (Holmes, 1997).  
Focal or partial seizures originate in a localized region and are confined to 
networks within one hemisphere of the brain (Berg et al., 2010).  Focal seizures include 
both simple and complex partial seizures. In a complex partial seizure, the individual 
exhibits impaired consciousness, meaning that they may not be aware or responsive.  
Simple partial seizures do not involve changes in consciousness, but may include some 
sensory auras (e.g., auditory, olfactory, visual hallucinations; McCandless, 2012).  
Etiology 
 Theories regarding the etiology of seizures and epilepsy have evolved over the 
last several decades.  The etiologic categorizations of epilepsy include idiopathic, 
symptomatic, provoked, and according to some researchers, cryptogenic.  Idiopathic 
seizures are those that have or are thought to have a genetic origin, and therefore do not 
have a specific neuroanatomical or pathological cause (Shorvon, 2011).  The defining 
characteristics of these seizures are age at onset, clinical and electrographic features, and 
an assumed genetic susceptibility (Berg et al., 2010).  Symptomatic epilepsy has an 
underlying cause that is associated with anatomical or pathological abnormalities.  This 
includes genetic disorders that are associated with pathological changes (e.g., tuberous 
sclerosis, West syndrome), as well as those that are acquired (e.g., head trauma, cerebral 
tumors or infection, neurodegenerative conditions).  Finally, cryptogenic epilepsy 
involves seizures with an unknown or unidentified cause.  Provoked epilepsy is a fourth 
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category used by some researchers.  Provoked epilepsy is linked to a specific 
environmental or systemic factor that causes the seizures in the absence of anatomical or 
pathological irregularities (e.g., toxin-induced, drug-induced, metabolic).  These factors 
can include genetic or acquired bases (Shorvon, 2011).   
 Berg and colleagues (2010) advised that the terms idiopathic, symptomatic, and 
cryptogenic had become too interwoven with different meanings and connotations within 
the field, which led to inconsistencies in their use.  They therefore proposed the following 
alternative terms: genetic, structural/metabolic, and unknown cause.  Genetic causes 
imply that the seizures are a direct result of either an identified or presumed genetic 
mutation. Structural/metabolic cause implies that there is a specific cause other than a 
genetic one that is directly related to the occurrence of seizures.  These include structural 
lesions and metabolic diseases that may impair metabolism or osmolality, or introduce 
toxins (O’Brien, 1998).  Lastly, unknown cause represents a neutral view that the 
underlying mechanism is unknown and may be related to an unidentified genetic 
correlate or another process that is not yet understood in relation to seizures (Berg et al., 
2010).   
 However, regardless of the terminology used to describe the potential cause of 
seizures, an important consideration is that many cases of epilepsy have multiple causes.  
Often both genetic and environmental influences impact the individual’s susceptibility to 
seizures and to developing epilepsy.  As one cause is often considered the predominant 
mechanism, using categories of causation has clinical utility but should not obscure other 
contributing factors.  
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Assessment and Treatment 
 Seizures and epilepsy are typically identified and diagnosed through clinical 
description and the use of electroencephalogram (EEG) to detect any abnormalities in 
neurological activity (Manford, 2001).  EEG patterns can identify epileptiform 
dischargers and determine whether these abnormalities are epileptic or non-epileptic 
paroxysmal attacks.  Different types of seizures (e.g., clonic, tonic) often show discrete 
EEG patterns, and this distinction can aid in accurate diagnosis (Noachtar & Rémi, 2009).  
The treatment for seizures depends on the type of seizure as well as individual 
characteristics.  Provoked seizures, which are caused by an identifiable source, are treated 
by addressing the specific anomaly that is thought to have triggered the seizure.  Seizures 
that are not provoked are often treated by anti-epileptic drugs (AED).  Common 
anticonvulsants include phenobarbital, valproate, carbamazepine, gabapentin, topiramate, 
oxcarbazepine, clobazam, phenytoin, lamotrigine, levetiracetam, rufinamide, lacosamide, 
and zonisamide (McCandless, 2012).  The type of AED prescribed typically depends on 
the type of seizure.  For example, certain AEDs (i.e., valproate, lamotrigine, and 
topiramate) are very effective in treating absence seizures, but others can cause 
deterioration (i.e., carbamazepine, tiagabine; Noachtar & Rémi, 2009).  Therefore, 
accurate assessment and diagnosis is crucial for treatment decisions.   
If multiple AEDs are not effective in controlling seizures, in some cases surgery is 
implemented as the next step.  Types of surgery include curative surgeries (i.e., resection 
of a seizure focus) and palliative surgeries (e.g., corpus callosotomy).  Vagus nerve 
stimulation is also sometimes used to reduced seizure by implanting a vagus nerve 
stimulator under the patient’s clavicle (Tarulli, 2016).   
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The ketogenic diet has also been promoted as a treatment for drug-resistant 
seizures.  The ketogenic diet is high in fat, low in protein, and low in carbohydrates.  This 
alteration in the body’s sources of energy is designed to elicit biochemical changes in the 
brain that are associated with starvation (Freeman et al., 1998).  This biochemical 
response causes the body to replace glucose as the brain’s source of energy with ketones 
(Hartman, Gasior, Vining, & Rogawski, 2007).  The results of several studies support the 
use of the ketogenic diet to control medication-resistant seizures (Groesbeck, Bluml, & 
Kossoff, 2006; Kinsman, Vining, Quaskey, Mellits, & Freeman, 1992; Neal et al., 2008).   
Prognosis 
The impact of seizures and epilepsy on individuals is far-reaching.  Researchers 
have found that individuals incur significant financial burden from seizure treatments.  
Factors that contribute to the cost of treatment include doctor visits, AEDs, tests and 
procedures, medical services and supplies.  Other financial considerations related to 
seizures are cost of social services, transport to and from treatment, specific medical 
equipment, and absence from work of school (Baker, Nashef, & van Hout, 1997).  More 
frequent seizures have also been found to be related to lower quality of life, as individuals 
with epilepsy encounter psychosocial difficulties such as higher rates of unemployment 
or underemployment (Smeets, van Lierop, Vanhoutvin, Aldenkamp, & Nijhuis, 2007), 
stigmatization, and lower self-fulfillment ratings (Baker et al., 1997).  Epilepsy-related 
mortality rates are also a concern, as mortality is more common in those who experience 
more frequent seizures than those whose seizures are better controlled (Baker et al., 
1997).    
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Seizures in Individuals with ASD 
 Researchers have suggested that ASD and epilepsy may share a molecular 
developmental mechanism.  The fact that some genetic disorders such as tuberous 
sclerosis and Fragile X syndrome are associated with both ASD and epilepsy provides 
some support for this theory (Brooks-Kayal, 2010; Reilly & Gillberg, 2016). One 
suggested explanation is that genetic mutations or the effects of seizures at a young age 
can impact synaptic plasticity and may influence the presence of both ASD and epilepsy 
(Brooks-Kayal, 2010).  Researchers have also proposed that deficiencies in GABergic 
signaling may be an underlying mechanism (Kang & Barnes, 2012), though the research 
on this association is limited.  Taken together, these studies emphasize the need for 
further research on the potential underpinning for atypical neurological activity and ASD.  
 Prevalence  
 Prevalence rates of seizures and seizure disorders are estimated to be higher in 
individuals with ASD than in the general population (Jokiranta et al., 2014).  Relatedly, 
researchers have found that the frequency of ASD diagnoses are higher in individuals 
with epilepsy than those without (Reilly et al., 2014; Saemundsen et al., 2007).  
Researchers have estimated the prevalence rate of seizures in individuals with ASD to be 
between 5-40% (Danielsson et al., 2005; Gabis et al., 2005; Hrdlicka et al., 2004; 
Jokiranta et al., 2014; Viscidi et al., 2013).  There is also evidence that prevalence may 
increase with age (Viscidi et al., 2013), so the differences in these rates may be due to 
sample characteristics of the studies, including age range, level of functioning, and 
definition of history of seizures (e.g., one seizure vs. diagnosis of epilepsy; Ballaban-Gil 
& Tuchman, 2000). 
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 In addition to seizures and epilepsy, researchers have also investigated rate of 
epileptiform abnormalities in individuals with ASD.  These findings indicate that in 
addition to higher rates of seizures in individuals with ASD than in the general 
population, the rates of epileptiform abnormalities are also higher (Hrdlicka et al., 2004; 
Kawasaki, Yokota, Shinomiya, Shimizu, & Niwa, 1997).  This has important 
implications for the understanding of the underlying mechanism for abnormal 
neurological activity in ASD.  
 Age at onset 
Several researchers have investigated the average age at onset of seizures and 
whether age is related to other factors, such as level of impairment.  Bishop (1985) found 
that, in a sample of children with Landau-Kleffner syndrome, earlier the age at onset had 
worse language prognoses.  O’Leary and colleagues (1981) reported consistent findings 
that children with onset of seizures prior to 5 years of age demonstrated greater cognitive 
impairments than those with later onset.  Similar results were reported based on a 
comparison of age of onset prior to 2 years of age versus later in life (Vasconcellos et al., 
2001), and there is also evidence that the relationship between age at onset and cognitive 
impairment is strongest early in life and decreases with age (Berg, Zelko, Levy, & Testa, 
2012).  However, contradictory findings indicate that age of onset may not be 
significantly related to intellectual (Ellenberg, Hirtz, & Nelson, 1984) or adaptive 
functioning (Berg et al. 2004).   
As previously mentioned, Rutter and Schopler (1987) suggested that seizures 
emerge later in individuals with ASD than those with ID, and typically occur in 
adolescence.  In a retrospective study conducted by Hara and colleagues (2007), the 
 17 
 
authors concluded the mean age at onset was 14 years, with a range of 8 to 26 years.  
Similarly, Bolton and colleagues (2011) found that the average age of emergence was 
13.3 years, and the majority of seizures began after age 10.  Researchers have suggested 
that the tendency for seizures to emerge in adolescence in individuals with ASD is 
associated with age-related neurological development (Bolton et al., 2011).   
 However, Mouridsen and colleagues (1999) and Danielsson and colleagues 
(2005) reported younger ages as onset of 8.1 year and 7.5 years, respectively.  Danielsson 
(2005) also found that one third of participants with ASD and epilepsy had their first 
seizure before 24 months of age, and suggested that the risk for epilepsy is highest in the 
first few years of life and decreases with age.  Nomura and colleagues (2010) further 
investigated age at onset, and found that there were two general “peak” ages at which 
epilepsy began in individuals with autism: early in childhood at 3.2 years of age, and in 
late adolescence at 16.7 years.  Similarly, researchers have suggested that seizure 
occurrence is highest in individuals with ASD at 5 and 10 years of age (Matson & Neal, 
2009). These findings may help to explain the discrepancies in reported age at onset 
across studies. 
Factors Associated with Seizures 
 Several interrelated factors are thought to be associated with the presence of 
seizures in individuals with ASD.  The most well-established is cognitive ability.  The 
bulk of the research on epilepsy and seizures and comorbid intellectual disability (ID) in 
individuals with ASD indicates that seizures are positively associated with lower 
cognitive or intellectual functioning (Amiet et al., 2008; Bolton et al., 2011; Danielsson 
et al., 2005; Gabis et al., 2005; Hrdlicka et al., 2004; Jokiranta et al., 2014; Viscidi et al., 
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2013).  Amiet and colleagues (2008) found that the rate of epilepsy was 21.4% in 
individuals with comorbid ASD and ID, but was only 8% in individuals with ASD 
without ID.  The authors further investigated this relationship and found that this 
increased prevalence rate was found only for individuals with an intelligence quotient 
(IQ) of less than 50 compared to those with an IQ of above 70; no significant differences 
in rates of epilepsy were found between those with IQ between 50 and 70 and those with 
IQs above 70.  This indicates that moderate and severe ID, but not mild ID, may be 
associated with increased rates of epilepsy.  These rates are consistent with those reported 
by Mouridsen and colleagues (2011), which were seizure rates of 33.7% for those with 
IQs below 70 and 8.8% for those without ID.   
In addition to lower cognitive functioning, Bolton and colleagues (2011) also 
found that individuals with epilepsy also had greater deficits in speech and language 
abilities, though this is in contrast to Shubrata and colleagues’ (2014) outcome that there 
were no differences in receptive or expressive language.  Although the relationship 
between seizures and language abilities is currently unclear, evidence of decreased 
cognitive functioning could be extrapolated to suggest that language impairments related 
to lower intellectual functioning may be associated with seizures and seizure disorder.  
 The second factor is severity of ASD symptomology.  Researchers have found 
that individuals in the more impaired range of autism symptoms have higher rates of 
abnormal electroencephalograms and epilepsy (Gabis et al., 2005).  Shubrata and 
colleagues (2014) also found that individuals with comorbid epilepsy had lower social 
quotient and higher scores on measures of autism symptoms (i.e., Childhood Autism 
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Rating Scale [CARS]).  This provides evidence that ASD symptoms may be related to the 
presence of epilepsy.   
However, there is some evidence that this relationship may be more strongly 
influenced by the level of cognitive functioning than core symptoms of ASD.  For 
instance, Viscidi and colleagues (2013) found that more severe ASD symptoms were not 
independently associated with epilepsy, as there was not a significant association after 
controlling for IQ.  This indicates that intellectual functioning may play more of a role in 
susceptibility to seizures than ASD symptomology, and Viscidi and colleagues (2013) 
suggested that children with ASD may be at an increased risk for epilepsy because they 
are at an increased risk for ID.  Interestingly, Smith and Matson (2010) reported that in a 
sample of adults with ID, those with comorbid ASD and epilepsy demonstrated greater 
impairment in social skills than those with ASD but without epilepsy.  These results 
indicate that in a sample of individuals with diagnoses of both ASD and ID, individuals 
with comorbid seizures had greater deficits in social functioning.  Overall, while the 
relationship between seizure disorders and autism symptomology independent of 
intellectual disability is not well established, there is some evidence of an association.   
 The third factor is gender, as females with ASD are more likely to experience 
seizures than males (Amiet et al., 2008; Bolton et al., 2011). Amiet and colleagues (2008) 
and Bolton and colleagues (2011) both reported prevalence of seizures in 30-34.5% of 
females and 18-18.5% of males with ASD.  This discrepancy is consistent with the 
findings of Danielsson and colleagues (2005), who suggested that epilepsy was present in 
58% of females and 32% of males.  However, other researchers have failed to find gender 
differences in prevalence (Hara, 2007).   
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Researchers have suggested that this may be connected to lower cognitive 
functioning in females with ASD compared to males (Danielsson et al., 2005; Gabis et 
al., 2005; Reilly & Gillberg, 2016).  Nonetheless, there is some evidence that these 
factors may be unrelated.  Blackmon and colleagues (2016) further investigated this 
relationship by examining treatment resistant epilepsy.  They found that females 
displayed higher rates of treatment resistant epilepsy, but also had lower overall autism 
symptom severity.  These results suggest that females with ASD and comorbid epilepsy 
may represent a subtype characterized by higher risk for epilepsy phenotype and less 
severe ASD symptoms.  This is consistent with the findings of Bolton and colleagues 
(2011) that the level of cognitive functioning and language skills did not differ 
significantly between males and females with comorbid ASD and epilepsy.  
 An additional factor that has been investigated is regression in young children 
with ASD.  Previous studies have yielded inconsistent results as to whether children who 
experience a regression are more likely to develop seizures.  For instance, some research 
implies that epileptiform abnormalities, paroxysmal abnormalities, and epilepsy were not 
associated with regression (Bolton et al., 2011; Canitano, Luchetti, & Zappella, 2005; 
Cuccaro et al., 2011; Kobayashi & Murata, 1998; Tuchman & Rapin, 1997).  In contrast, 
other researchers have found that regression was more frequent in individuals with 
epilepsy than those without (Hrdlicka et al., 2004).  Similarly, Giannotti and colleagues 
(2008) reported that epilepsy and epileptiform abnormalities were more common in 
children with ASD who regressed than those who did not.  However, despite some 
evidence for this association, the research overall does not support a potential relationship 
between regression and epilepsy.   
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Assessment and Treatment Considerations 
 A diagnosis of ASD may indicate certain barriers to the identification of a seizure 
disorder.  Core symptoms of ASD, such as lack of response to socially salient stimuli 
(e.g., responding to name, voices) or repetitive behaviors, may obscure seizure symptoms 
(Jokiranta et al., 2014; Peake, Notghi, & Philip, 2006; Reilly & Gillberg, 2016).   Given 
the high prevalence of seizures and seizure disorders in individuals with ASD, clinicians 
are encouraged to consider this potential comorbidity during assessment (Matson & Neal, 
2009).  
Individuals with epilepsy are at risk for cognitive impairment (Berg, Zelko, Levy, 
& Testa, 2012) and behavioral abnormalities (Elger, Helmstaedter, & Kurthen, 2004; 
Vingerhoets, 2006).  Baker and colleagues (2011) found that individuals with recent 
diagnoses of epilepsy demonstrated a distinct cognitive trajectory compared to those 
without epilepsy, and specifically displayed declines in memory, psychomotor speed and 
executive functioning over the course of a year.  The use of AEDs has also been 
implicated in cognitive deficits, possibly due to neuronal sensitivity and excitability 
(Meador, 2002).  Berg and colleagues (2004) also found that young children with onset of 
seizure before age 3 showed declines in age appropriate adaptive skills over time.  As 
cognitive impairments and adaptive skill deficits are already present in many individuals 
with ASD, the presence of comorbid seizures or epilepsy have significant implications 
for functioning in this population.  As previously mentioned, although the association 
between ASD and seizures is well-established, little is currently known about the 
mechanisms that underlie this relationship.  Consequently, early identification and 
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effective treatment of seizure disorders are crucial steps in optimizing outcomes for 
individuals with ASD.   
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Purpose 
 Many individuals with ASD have co-occurring psychiatric disorders or medical 
concerns, and disorders such as epilepsy can complicate the diagnostic process as well as 
treatment planning.  Although many researchers have investigated possible neurological 
differences between individuals with ASD and TD individuals, the relationship between 
ASD and neurological dysfunction (such as that characteristic of epilepsy or epileptiform 
abnormalities) is still unclear.  However, the literature does suggest that individual with 
more severe ASD symptomology and cognitive impairment show higher rates of seizures 
or seizure disorders (Amiet et al., 2008; Bolton et al., 2011; Gabis et al., 2005).  These 
findings indicate that there may be neurological underpinnings to ASD in some 
individuals (Tuchman & Rapin, 2002).  
 The current study aimed to examine the relationship between ASD diagnosis and 
a history of seizures and autism symptom severity. Although the previous literature 
suggests that severe autism symptomology is related to comorbid seizures (Gabis et al., 
2005), very few studies have investigated specific symptoms.  Additionally, few 
researchers have explored this association in children under the age of 3.  Expanding this 
line of research to younger children may help to elucidate whether these differences are 
consistent early in life, or if they become more apparent with age.  Therefore, the current 
study investigateed differences in total symptomology as well as symptoms within 
specific domains (i.e., social communication, restricted repetitive interests and behaviors, 
and communication) in infants and toddlers with and without a history of seizures and 
with and without an ASD diagnosis.  The extant literature on ASD and seizure disorders 
provides some evidence that ASD symptoms may be exacerbated in individual with ASD 
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and co-occurring seizures (Gabis et al., 2005; Shubrata et al., 2014).  Therefore, it was 
hypothesized that across both total and domain scores individuals with comorbid ASD 
and a history of seizures would have the highest symptomology, followed by the ASD 
without seizures group, and the atypical group without seizures will have the lowest 
scores.  The results of the current study may have clinical implications for assessment 
and treatment of ASD comorbid with a history of seizures or seizure disorder.  
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Method 
Participants 
All participants were enrolled in EarlySteps, Louisiana’s statewide early 
intervention program under the Individuals with Disabilities Education Act, Part C.  The 
data for this study were extracted from an existing dataset containing assessment 
information.  Children under 3 years of age qualify for EarlySteps services if they have or 
are at risk for a developmental delay.  Therefore, all participants included from this 
dataset had some form of atypical development. Only participants between the ages of 17 
and 37 months at the time of assessment were included in the analyses.   
Participants were assigned to groups based on whether they meet criteria for ASD 
and whether they had a history of seizures or a seizure disorder.  Diagnoses of ASD were 
given by a licensed clinical psychologist based on an algorithm in accordance with the 
Diagnostic and Statistical Manual, Fifth Edition (DSM-5, American Psychiatric 
Association, 2013).  A classification of a history of seizures or seizure disorder was based 
on parental report of any seizures on the demographic subsection of the Baby and Infant 
Screen for Children with aUtIsm Traits (BISCUIT; Matson, Boisjoli, & Wilkins, 2007).  
Participants were assigned to one of four groups: an atypical development group without 
a history of seizures (ATYP), an atypical group with a history of seizures (ATYP+SEIZ), 
an ASD only group without history of seizures (ASD), and a comorbid ASD and seizures 
group (ASD+ SEIZ).  
A statistical power analysis program, G*POWER, was used to establish necessary 
samples size for the four groups in order to demonstrate adequate power.  A power of .80 
(Field, 2013), alpha of .05, and medium effect size of ƞ2 = .25 were used, as these values 
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are considered acceptable and consistent with previous research in the field.  The results 
of this analysis indicated that a total sample size of 180, or approximately 45 participants 
per group, would yield the appropriate power and effect size for a one-way ANOVA, and 
a total sample size of 24 would yield the appropriate power for the MANOVA.  
 
Figure 1. Participant Inclusion Flowchart 
The total number of cases in the dataset was 17,996.  Cases were excluded if the 
evaluation was conducted prior to 2010 or if there was missing data.  Exclusion of cases 
entered prior to 2010 was to control for the potential effects of a natural disaster in the 
region (i.e., flooding and displacement due to Hurricane Katrina) on children who were 
born prior to that event.  As none of the cases with missing data were in the smallest 
group (ASD+SEIZ) and therefore deletion did not affect the total sample size for the 
study, deletion of these cases was used rather than estimation of missing data 
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(Tabachnick & Fidell, 2007).  If a participant had received more than one evaluation, the 
most recent was included in the analyses.  For the exact number of cases excluded, see 
Figure 1. 
The total number of cases remaining was 9,410 (i.e., 8,164 ATYP, 1,024 ASD, 
174 ATYP+SEIZ, and 48 ASD+SEIZ).  Due to unequal sample sizes between groups, 
participants from each group were age and gender and gender matched to the smallest 
group (i.e., ASD+SEIZ).  This matching procedure was used because, as previously 
discussed, previous research has shown that there are age and gender effects related to 
seizures and developmental functioning, so these demographic factors were controlled for 
through matching to the smallest group. This resulted in a total of 192 participants, with 
48 participants in each group.  For one participant in the ATYP+SEIZ group, it was not 
possible to match exactly for age and gender. Consequently, this case was matched with a 
case within one month of age (e.g., 24 months instead of 23 months).  The age range for 
the participants was 17-35 months (M = 25.89, SD = 4.59).  In regard to the total sample, 
58.3% were male (n = 112) and 41.7% (n =80) were female.  With respect to participant 
race, 47.9% were African American (n = 92), 42.2% were Caucasian (n = 81), 4.2% were 
Hispanic (n = 8), and 5.7% were of another race (n = 11).  Group demographic 
information is presented in Table 1.   
Measures 
Baby and Infant Screen for Children with aUtIsm Traits, Part 1 (BISCUIT-
Part 1; Matson et al., 2007).  
The BISCUIT is an informant-report measure designed for young children 17 to 
37 months of age.  This measure consists of three sections which evaluate ASD 
symptomology, comorbid psychopathology, and challenging behaviors. The BISCUIT-
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Part 1 assesses ASD symptoms and consists of 62 items related to nonverbal and verbal 
communication, socialization, and repetitive behavior/restricted interests. Each of these 
items is rated based on a 3-point Likert scale that compares the child to same-aged peers. 
A rating of 0 corresponds to “not different; no impairment”, a rating of 2 corresponds to 
“somewhat different; mild impairment”, and a rating of 3 corresponds to “very different; 
severe impairment”.  This measure includes age-based cut-off ranges for the total 
BISCUIT score; a score of 0-16 falls within the “No ASD/Atypical Development” range; 
a score of 17-38 falls within the “Possible ASD” range; and a score of 41-124 falls within 
the “Probable ASD” range. Therefore, a score of 17 or higher is classified as in the “at 
risk” range.  The Socialization/Nonverbal Communication subscale consists of 24 items, 
the Repetitive Behavior/Restricted Interests subscale includes 23 items, and the 
Communication subscale includes 7 items.  
Table 1. Demographics 
The BISCUIT-Part 1 has an estimated internal reliability of .87 and overall 
correct classification rate of .89 ( Matson et al., 2009).  The BISCUIT-Part 1 has also 
 ATYP 
 (n = 48) 
ATYP+SEIZ 
(n = 48) 
ASD 
(n = 48) 
ASD+SEIZ 
(n=48) 
Mean Age (in months) 25.88  25.90 25.88 25.88 
     SD (in months) 4.47 4.72 4.74 4.74 
Gender     
     Male  
     Female 
28 (58.3%) 
20 (41.7%) 
28 (58.3%) 
20 (41.7%) 
28 (58.3%) 
20 (41.7%) 
28 (58.3%) 
20 (41.7%) 
Race     
    African American  
    Caucasian 
    Hispanic 
    Other 
23 (47.9%) 
19 (39.6%) 
5 (10.4%) 
1 (2.1%) 
18 (37.5%) 
27 (56.3%) 
0 (0%) 
3 (6.3%) 
24 (50.0%) 
20 (41.7%) 
1 (2.1%) 
3 (6.3%) 
27 (56.3%) 
15 (31.3%) 
2 (4.2%) 
4 (8.3%) 
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been found to have convergent validity with the Modified Checklist for Autism in 
Toddlers (M-CHAT) and the Personal-Social domain of the Battelle Developmental 
Inventory, Second Edition (BDI-2), as well as divergent validity through small correlation 
with the BDI-2’s Adaptive and Motor domains (Matson, Wilkins, & Fodstad, 2011).  The 
present study used the BISCUIT-Part 1 total score and domains scores, as well as the 
demographic form.  The demographic form is used to collect information regarding the 
participant’s demographic variables, family history, and developmental and medical 
history. The BISCUIT-1 total score were used to assess ASD symptom severity, and the 
subscale scores were used to assess symptomology across nonverbal 
communication/socialization, repetitive behavior/restricted interests, and communication.  
Procedure 
The Louisiana State University institutional review board and the State of 
Louisiana’s Office for Citizens with Developmental Disabilities approved the study prior 
to data collection.  The BISCUIT-Part 1 were administered by service providers at the 
participant’s home or daycare center as part of an assessment battery that included 
caregiver interviews and direct observation.  All service providers attended trainings on 
the administration of the assessment measures and held a degree, certification, and/or 
licensure in various related fields such as occupational therapy, physical therapy, 
psychology, special education, and speech-language pathology.  Only records collected 
between 2010-2016 were included in the statistical analyses.   
 The data used for the present study were from a research database of de-identified 
archival records. Consequently, the Institutional Review Board determined that the 45 
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CFR part 46 of the U.S. Department of Health and Human Services regulation does not 
apply and informed consent was not required.  
Statistical Analyses 
 Bivariate and univariate analyses were conducted to investigate the following 
research questions: 1) does autism symptom severity differ based on a history of seizures 
or seizure disorder and 2) does a history of seizures or seizure disorder impact separate 
domains of ASD symptoms differently?  The four groups were age and gender-matched 
to the smallest group, so a priori analyses of differences in these demographic variables 
were not included, though a chi-square analysis was conducted to assess differences in 
race between groups.  Descriptive statistics were conducted for total scores on the 
BISCUIT-Part 1 and the three subscales.   
 An analysis of variance (ANOVA) was conducted to examine the relationship 
between group and total ASD symptom severity.  The independent variable (IV) was 
group (i.e., ATYP, ASD, ATYP+SEIZ, and ASD+SEIZ) and the dependent variable 
(DV) was ASD symptom severity, based on the total BISCUIT-Part 1 score.  Post hoc 
tests were used to further examine differences between groups.  A multivariate analysis 
of variance (MANOVA) was conducted with group as the IV and scores from the three 
ASD symptom subscales (i.e., Socialization/Nonverbal Communication, Repetitive 
Behavior/Restricted Interests, Communication) as the DVs.  Post-hoc comparisons were 
done to further investigate differences between groups.    
  
 31 
 
Results 
Bivariate analyses were not conducted for age or gender because matching was 
applied to all group; however, the results of a chi-squared analysis revealed no significant 
differences between groups in regard to race, χ2 (9) = 14.25, p = .114).  Internal 
consistency for the 62 items on the BISCUIT Part-1 was estimated to be a = .97.  Prior to 
performing the initial ANOVA, the data were checked for outliers in total score on the 
BISCUIT-Part 1.  Results indicated that there were outliers in the ATYP and ASD+SEIZ 
groups.  A square root transformation was then applied to the score dependent variable to 
address these outliers because the scores were moderately positively skewed.  Due to the 
large samples size (n > 50), normal distribution was assessed by Normal Quantile-
Quantile (Q-Q) rather than by the Komogrov-Smirnov and Shapiro-Wilks tests (Field, 
2013; Laerd, 2015).  Based on visual analysis of Normal Q-Q Plots, it was determined 
that scores for all three subscales were normally distributed.  The initial ANOVA showed 
significant differences in total symptom severity between groups, F (3,188) = 90.97, p > 
.001, partial η2 = .592.  Descriptive statistics for the total BISCUIT-Part 1 scores across 
groups are provided in Table 2.  Levene’s Test of Equality of error variance was 
significant (p = .023), so Games-Howell post hoc tests were used.  The results of Games-
Howell post hoc tests indicated that all groups had significantly different total scores on 
the BISCUIT- Part 1 (p < .001).  
Prior to conducting the MANOVA, the assumptions for this analysis were 
checked.  There were univariate outliers in the data for all three subscales of the 
BISCUIT- Part 1, as determined by inspection of boxplots for values greater than 1.5 
lengths from the box.  Based on observation of histograms, it was determined that the 
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data for the Socialization/ Nonverbal communication and RRBIs domains subscales was 
strongly positively skewed, while the Communication domain was strongly negatively 
skewed.  Therefore, logarithmic transformations were conducted for the first two 
subscales and a reflect and logarithmic transformation was applied to the Communication 
domain. Following these transformations, there were no univariate outliers for the any of 
the domains.  Based on visual analysis of Normal Q-Q Plots, it was determined that 
scores for all three subscales were normally distributed.  Multicollinearity was assessed 
through a linear regression analysis using the principle proposed by Belsley, Kuh, and 
Welsch (1980; from Tabachnick & Fidell, 2007).  Although the final dimension had more 
than one variance proportion greater than .50, none of the condition indices approached 
30; therefore, multicollinearity was not detected.  There was a linear relationship between 
the Socialization/Nonverbal Communication, RRBIs, and Communication as assessed by 
scatterplot.  There were no multivariate outliers, as assessed by Mahalanobis distance (p 
> .001), using a critical value of 16.27 based on the number of dependent variables.  
Table 2.  Autism symptom severity comparison between groups 
 ATYP 
M (SD) 
ATYP+SEIZ 
M (SD) 
ASD 
M (SD) 
ASD+SEIZ 
M (SD) 
BISCUIT-Part 1:    
ASD Symptom Severity 
18.54 (14.92)bcd 32.50 (18.75)acd 75.79 (19.61)abd 57.69 (21.76)abc 
Socialization/Nonverbal 
Communication 
5.58 (7.99)bcd 13.48 (11.32)cd 33.48 (9.14)abd 26.21 (12.02)abc 
Restricted/Repetitive 
Behaviors/Interests 
4.06 (5.02)cd 6.38 (6.18)cd 23.10 (10.17)abd 16.19 (9.74)abc 
     
Communication 7.13 (3.81)bcd 10.23 (2.05)ac 12.38 (2.01)ab 11.40 (2.89)a 
     
a. Significantly different from ATYP, p < .05  Note: M = Mean; SD = Standard Deviation. 
b. Significantly different from ATYP+SEIZ, p < .05 
c. Significantly different from ASD, p < .05 
d. Significantly different from ASD+SEIZ, p < .05  
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A MANOVA was then conducted to evaluate scores across symptom domains 
(see Figure 2).  There was not homogeneity of variance-covariances matrices, as assessed 
by Box’s test of equality of covariance matrices (p < .001).  Although the sample sizes 
across groups were equal and therefore a violation of this assumption is typically not 
considered a concern, Pillai’s Trace was used rather than Wilks’ Lambda as it is more 
robust to violations of assumptions (Field, 2013; Laerd Statistics, 2013).  There was not 
homogeneity of variances for any of the subscales, as assessed by Leven’s Test of 
Equality of Error Variances (p < .001 for Socialization/Nonverbal Communication and 
RRBIs, and p = .019 for Communication).  Therefore, Games-Howell post hoc tests were 
conducted for follow-up ANOVAs (Laerd Statistics, 2015). 
 
Figure 2. Mean Group Scores Across Subscales 
According to Pillai’s trace, there were significant differences between groups 
across symptoms, V = .644, F(9,564) = 17.13, p < .001, partial η2 = .215.  Follow-up 
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ANOVAs were also conducted, and a Bonferroni correction (p < .017) was used to 
account for multiple comparisons.  There were significant differences between groups for 
all three domains: Socialization/nonverbal communication domain, F (3,188) = 73.88, p 
> .001, partial η2 = .541; RRBI domain, F(3,188) = 63.55, p > .001, partial η2 = .504, 
and the Communication domain F(3,188) = 25.78, p > .001, partial η2 = .292.  
Games-Howell post hoc tests were conducted to evaluate differences between 
groups across symptom domains because the assumption of homogeneity of variances 
was violated (Laerd Statistics, 2015).  For the Socialization/Nonverbal communication 
domain, the ASD+SEIZ group had significantly higher score than both the ATYP and 
ATYP+SEIZ groups (p < .001) and significantly lower scores than the ASD group (p = 
.003).  The ATYP+SEIZ group also had significantly higher scores than the ATYP group 
(p < .001) and lower scores than the ASD group (p < .001).  Lastly, the ASD group also 
had significantly higher scores than the ATYP group (p < .001).  
For the Restricted/repetitive behaviors and interest domain, the ASD+SEIZ group 
had significantly lower scores than the ASD group (p = .002) and higher scores than both 
the ATYP and ATYP+SEIZ groups (p < .001).  The ATYP+SEIZ group had significantly 
lower scores than the ASD group (p < .001), but did not differ significantly from the 
ATYP group (p = .094).  The ASD group also had significantly higher scores than the 
ATYP group (p < .001).  
In regard to the Communication subscale, the ATYP group had significantly 
lower scores than all three of the other groups (p < .001).  The ATYP+SEIZ group had 
significantly lower scores than the ASD group (p = .001), but did not differ significantly 
from the ASD+SEIZ group (p = .194).  ASD group also had significantly higher scores 
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than the ATYP (p < .01) and the ATYP+SEIZ (p = .001) groups.  Significant differences 
were not found for the ASD and ASD+SEIZ groups on this domain (p = .365).  
Descriptive statistics for the BISCUIT-Part 1 subscale scores across groups are provided 
in Table 2.  
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Discussion 
ASD symptomology, as measured by the BISCUIT-Part 1, was compared 
between groups of participants with atypical development, atypical development and 
comorbid seizures, ASD, and comorbid ASD and seizures.  Total ASD symptom scores 
were examined, as well as symptoms on three symptom domains: Socialization/nonverbal 
communication, Restricted/repetitive behaviors and interests, and Communication.   
The findings of this study indicated that there were significant differences 
between groups for the total BISCUIT-Part 1 scores as well as between most groups for 
symptom domains.  Across all IVs, the ASD group had the highest scores, followed by 
the ASD+SEIZ group, then the ATYP+SEIZ group, with the ATYP group evincing the 
lowest scores.  Differences were significant between all four groups for the total score 
and Socialization/nonverbal communication.  The majority of comparisons were 
significant for the other two domains.  Exceptions included the ATYP and ATYP+SEIZ 
groups for the RRBIs domain and the ASD+SEIZ and the ASD and ATYP+SEIZ groups 
for the Communication subscale.  
The general trend of these findings was that for individuals with ASD, a history of 
seizures indicated lower endorsement of symptoms.  Conversely, for individuals without 
ASD, a history of seizures was related to higher overall symptomology.  These results 
contradict some previous findings that individuals in the more impaired range of ASD 
(i.e., autism rather than Asperger’s syndrome or PDD-NOS) demonstrate higher 
likelihood to experience seizures (Gabis et al., 2005), as comorbid seizures were 
associated with lower rates of ASD symptoms in the current study.  Other researchers 
have found that, based on DSM-IV-TR diagnoses, epilepsy occurs at higher rates in both 
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autistic disorder and PDD-NOS than in Asperger’s syndrome (El Achkar & Spence, 
2015).  Nonetheless, given that there is a well-documented relationship between seizures 
and ID, these results are consistent with the assumption that children with seizures may 
have more cognitive impairment than those without seizures.   Therefore, atypically 
developing children with seizures and therefore potential ID may exhibit more symptoms 
related to ASD (e.g., language delays, motor stereotypies) than those without ASD or 
seizures.  Further, in young children with ASD, those with comorbid seizures and 
possible lower cognitive functioning may have lower overall developmental functioning.  
This does not, however, necessarily suggest more autism-specific symptoms but rather 
more global impairments.  
For the RRBIs subscale, a history of seizures was not related to significantly 
higher levels of restricted, repetitive interests and behaviors in the atypically developing 
sample.  Conversely, in the ASD sample, those without a history of seizures had 
significantly higher scores on the RRBIs domain than those with seizures. This finding 
may suggest that in atypically developing children, neurological differences related to 
seizures may not be significantly associated with increases in restricted, repetitive 
interests and/or behaviors in individuals without ASD.  The differences between the ASD 
and atypically developing groups may indicate that seizures may be more closely related 
to RRBIs in young children with ASD, but less intertwined in children without ASD.   
A history of seizures also seemed to be less robustly related to communication 
and language skills, as there were fewer significant differences between groups for this 
domain. Specifically, the Communication score in the ASD+SEIZ group did not differ 
from ASD or ATYP+SEIZ groups.  The results for this domain indicated that the 
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atypically developing group had significantly less impairment in communication than the 
other three groups, but that those with atypical development and seizures did not have 
significantly fewer communication difficulties than those with ASD and seizures.  
Further, the ASD group did not have significantly worse communication skills than the 
ASD+SEIZ group.  These results indicate that seizures may play more of a role in 
impairments in communication than an ASD diagnosis.  Of note, this finding may be 
accounted for by the small number of items (7 as compared to 24 and 23).  Given that this 
domain is not a diagnostic criterion for ASD according to DSM-5, and the fact that there 
are so few items, these findings may have less substantial implications for the field.  
However, because so many children with ASD do experience language delays and 
impairments, this subscale was included in the analyses to examine general trends 
between groups.  
An important consideration in the interpretation of these findings is the very 
young age of the participants.  Previous research indicates that many individuals do not 
develop seizures until later in childhood or adolescence (Bolton et al., 2011; Hara et al., 
2007).  There is substantial evidence that earlier onset of seizures may be related to 
greater cognitive impairment (Berg et al., 2012; O’Leary et al., 1981; Vasconcellos et al. 
2001).  Physical disabilities such as motor impairments may also be more prevalent in 
children with seizures (McGrother et al., 2006).  Therefore, this sample may represent a 
group of children with greater global delays associated with early onset seizures, which 
may account for some of the observed differences between groups.  
Additionally, it is likely that many of the children whose seizures had been 
identified at this young age were exhibiting types of seizures with more visible motor 
 39 
 
features (e.g., tonic-clonic seizures), rather than less obvious symptoms (e.g., absence 
seizures), which would be more difficult to identify in younger children, particularly with 
communication deficits.  Therefore, it is possible that some children in this sample may 
have had undiagnosed seizures at the time of assessment.   
Overall, the evidence that a history of seizures may be significantly related to 
autism symptomology both in atypically developing children and those with ASD 
highlights the importance of early identification.  In this sample, those with ASD and 
comorbid seizures had lower autism symptomology scores than those without seizures, 
and it is possible that this is due to impairments in cognitive functioning.  Further, young 
children without ASD had higher scores of ASD symptomology if they had a history of 
seizures, which may indicate impairments in the three domains discussed even in the 
absence of a diagnosis of a developmental disability when there is abnormal neurological 
activity.   
Although there is currently a lack of consensus in the field regarding screening 
procedures for epilepsy in those with ASD, this study supports the recommendations of 
researchers such as El Achkar and Spence (2015) that providers be proficient in 
differentiating ASD symptoms from potential indicators of seizures.  Given the increased 
prevalence of seizures in the ASD population (Jokiranta et al., 2014) and the potential 
association with symptomology (Gabis et al., 2005) and cognitive impairments (Amiet et 
al., 2008; Bolton et al., 2011; Danielsson et al., 2005), providers should take additional 
care in considering the likelihood of seizure disorder.  
Early identification of seizures in young children with ASD is crucial, as 
researchers have recommended that individuals with this comorbidity may evince 
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different patterns of symptoms and may require longitudinal follow-up throughout 
development to monitor the seizures (Shubrata et al., 2014).   Tuchman and colleagues 
(2010) suggested that early recognition and diagnosis of seizures may also help identify 
children who may be at-risk for ASD, given the high incidence of these two conditions.  
Early treatment of seizures, such as medication or lifestyle changes, may help to improve 
outcomes for individuals with ASD (Tuchman et al., 2010).  However, Reilly & Gillburg 
(2016) caution that consideration of potential side effects of anti-epileptic medication 
should be considered in this population.  
Limitations  
 One limitation to the current study is the lack of a typically developing 
comparison group.  Given that children were included in the EarlySteps database if their 
caregivers requested an evaluation due to concerns regarding their child’s development, 
most children in this sample evinced some sort of developmental delay or medical 
concern.  Although this allowed for a comparison between children with and without 
ASD and with and without a history of seizures, these results may not be generalizable to 
comparisons between children with ASD and typically developing children.  
Additionally, the BISCUIT demographic form is a caregiver-report measure, and 
therefore classification of having a history of seizures was based solely on caregiver 
report and was not validated through medical records.  Finally, the results for the 
Communication subscale should be interpreted with caution due to the small number of 
items in this domain.  This domain was still included in the analyses because many 
children with ASD experience language delays.   
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Future Directions 
These findings highlight the need for additional research on how seizure disorders 
affect symptom presentation in children with ASD.  This study provides preliminary 
evidence that seizures in individuals with ASD may be related to lower levels of autism-
specific symptoms as compared to children with ASD alone.  These results should be 
further investigated, both in young children as well as in older children where ID can be 
investigated as a variable to further elucidate the relationship between autism 
symptomology, intellectual disability, and seizures.  The sample of participants used in 
this study was too young for an ID diagnosis to be used as a reliable variable in the 
present analyses, but it is hypothesized that the findings on a history of seizure disorders 
may be associated with lower cognitive functioning.  Although many studies have 
considered comorbidity of ASD, ID, and seizure disorders, the majority have focused on 
cognitive functioning and few have investigated autism symptomology specifically.  
As the current study relied upon caregiver-report of a history of seizures, 
information regarding the type or frequency of seizures was not available.  Although 
some studies have focused on specific types of seizures (Reilly & Gillburg, 2016), 
additional research is warranted.  Further, the demographics of this sample upheld 
previous research that female gender may serve as a risk factor for epilepsy in individuals 
with ASD (El Achkar & Spence, 2015).  Despite the overall gender ratio of 4-5:1 male to 
female with ASD (Baio, 2014), the sample of individuals with ASD used in this study 
included 28 males and 20 females, which is a more even gender split than the general 
ASD population.  Although gender was not included as a variable in this study due to the 
age and gender matching procedure applied to the four groups, future investigation of the 
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differences between males and females with comorbid ASD and seizures may help to 
elucidate the relationship between seizures, ASD, and ID.   
Future studies involving young children should be considered to further clarify 
symptom patterns in very young children with a history of seizures.  As the literature 
indicates that seizure disorders do not develop or are not diagnosed until later in 
childhood, additional investigation of how seizures early in development relate to ASD 
and associated impairments is warranted. 
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